Intraoperative Cell Saver Autotransfusion Use for Major Surgical Oncology Operations.

Completed

Conditions studied: Pancreaticoduodenectomy, Pancreatectomy, Esophagectomy, Gastrectomy, Hepatectomy

In brief

The purpose of this study is to demonstrate the safety and benefit of auto-transfusion filtered blood in patients undergoing major surgical oncology procedures.

Key facts

Study ID

NCT00708513

Run by

University of Louisville

People needed

98

Starts

2003-12-01

Expected to finish

2009-12-01

Last updated by the study team

2013-10-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject is undergoing a major surgical oncology procedure and has potential for extensive blood loss.
• Subject is ≥ 18 years of age.
• Subject or Subject's Legally Authorized Representative (LAR) has signed an IRB-approved informed consent form.

You may not qualify if…

• Subject has medical, social, or psychological factors that, in the opinion of the Investigator, could impact safety or compliance with study procedures.
• Subject is < 18 years of age.
• Subject or Subject's LAR did not sign IRB-approved informed consent form.

Where it is running

• Norton Healthcare — Louisville, Kentucky, United States
• University of Louisville Hospital — Louisville, Kentucky, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.